The Longevity Evidence Ladder: How to Act on New Health Research After 40
A practical framework for separating actionable longevity evidence from promising findings that still need human validation.
The Masters Athlete Paradox: Fit for Longevity, Not Immune to Heart Risk
High fitness remains protective, but masters athletes can still develop arrhythmias and coronary plaque; a practical audit helps identify meaningful changes.
Why Self-Reported Sleep Misleads After 40, and How to Measure Yours Better
Almost everything you believe about your own sleep comes from a questionnaire or an app summary, and new 2026 data shows that layer fails hardest in the brains that need it most.
The Minimum Effective Dose for Longevity: What 30 Years of Mortality Data Show
The strongest long-term mortality studies agree on something counterintuitive: the biggest longevity gains come from modest doses of strength, walking, and whole foods, and the benefit plateaus early.
The ‘Healthy Average’ Trap: Why Standard Targets for Vitamin D, Sleep, and Diet Can Miss You
Public health targets are built on population averages, and the average can quietly misdescribe the individual standing in front of it, you.
Heat as a Training Stimulus: What Deliberate Heat Does to Your Cells and Your Endurance
Deliberate heat triggers a real cellular stress response and expands your blood volume; here is what the human evidence supports, what is still speculative, and how to use heat without overreaching.
Choline, Eggs, and the Aging Brain: What the Evidence Actually Supports
One nutrient keeps surfacing in dementia research, most adults over 40 fall short of it, and the fix is mostly on your plate.
Cognitive Longevity After 40: Build Your Baseline Before Chasing Biomarkers or Supplements
Cognitive longevity is best approached as a measurable, multi-domain practice, not a race to buy a blood test or a supplement.
The Muscle You Lose on a GLP-1 Drug: Protecting Lean Mass in the Wegovy Pill Era
GLP-1 weight loss drugs strip fat and muscle together; here is how adults over 40 can protect lean mass while the scale drops.
Frailty During Cancer Treatment: The Longevity Lever the Metformin Debate Keeps Missing
A 2026 study shows worsening frailty during breast cancer treatment predicts long-term quality-of-life decline; here is why strength, not a pill, is the target you can actually move.